Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

India’s Advinus Signs On With Genzyme In Malaria Research

This article was originally published in PharmAsia News

Executive Summary

Anti-malarial drug research involving Genzyme and others is set to expand with the help of new Indian partner Advinus, just taken on board to develop early-stage candidates
Advertisement

Related Content

Genzyme CEO Henri A. Termeer On Big Pharma’s Transformation To Becoming Leaner Machines: An Interview With PharmAsia News (Part 2 of 2)
Genzyme CEO Henri A. Termeer On Big Pharma’s Transformation To Becoming Leaner Machines: An Interview With PharmAsia News (Part 2 of 2)
Genzyme Firms Up Long Term, High Investment Plans For India
Genzyme Firms Up Long Term, High Investment Plans For India
J&J Teams With Advinus For Drug Discovery In India
J&J Teams With Advinus For Drug Discovery In India
Merck Targeting Metabolic Disorders With Advinus Deal
Merck Targeting Metabolic Disorders With Advinus Deal
Advertisement
UsernamePublicRestriction

Register

SC069388

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel